Accelerate Diagnostics Inc
OTC:AXDXQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Accelerate Diagnostics Inc
OTC:AXDXQ
|
US |
|
V
|
Vita 34 AG
XMUN:V3V
|
DE |
|
STL Global Ltd
BSE:532730
|
IN |
|
H
|
Heidelberg Materials AG
SWB:HEI
|
DE |
|
P
|
Philip Morris International Inc
F:4I1
|
US |
|
Barry Callebaut AG
SIX:BARN
|
CH |
|
A
|
American Express Co
DUS:AEC1
|
US |
|
M
|
MercadoLibre Inc
DUS:MLB1
|
UY |
|
L
|
Landstar System Inc
SWB:LDS
|
US |
|
FormFactor Inc
NASDAQ:FORM
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AXDXQ's stock price target?
Not Available
AXDXQ does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Accelerate Diagnostics Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 1 year is 7%.